Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma

Clinical trial NCT06773377 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06773377
Sponsor: Assiut University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Renal Cell Cancer

Start date: 2025-11-01
Primary completion: 2026-11-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.